FGGY-CDH17 Fusion FISH Probe
The FGGY-CDH17 Fusion FISH Probe is used to confirm a fusion of the FGGY and CDH17 genes. The fusion of the FGGY and CDH17 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
FGGY-CDH17-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-RERE | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-REOR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-REGO | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-REGR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-REAQ | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-ORRE | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-OROR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-ORGO | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-ORAQ | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GORE | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GOOR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GOGO | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GOGR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GOAQ | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GRRE | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GROR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GRGO | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GRGR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-GRAQ | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-AQRE | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-AQOR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-AQGO | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-AQGR | 20 (40 μL) | 200 μL | ||
FGGY-CDH17-20-AQAQ | 20 (40 μL) | 200 μL |
CDH17 Gene Summary
This gene is a member of the cadherin superfamily, genes encoding calcium-dependent, membrane-associated glycoproteins. The encoded protein is cadherin-like, consisting of an extracellular region, containing 7 cadherin domains, and a transmembrane region but lacking the conserved cytoplasmic domain. The protein is a component of the gastrointestinal tract and pancreatic ducts, acting as an intestinal proton-dependent peptide transporter in the first step in oral absorption of many medically important peptide-based drugs. The protein may also play a role in the morphological organization of liver and intestine. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2009]
Gene Name: Cadherin 17
Chromosome: CHR8: 95139393 -95229531
Locus: 8q22.1
FGGY Gene Summary
This gene encodes a protein that phosphorylates carbohydrates such as ribulose, ribitol, and L-arabinitol. Genome-wide association studies in some populations have found an association between polymorphisms in this gene and sporadic amyotrophic lateral sclerosis, but studies of other populations have not been able to replicate this association. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Gene Name: FGGY Carbohydrate Kinase Domain Containing
Chromosome: CHR1: 59762624 -60228402
Locus: 1p32.1
Gene Diseases
The FGGY CDH17 Fusion has been associated with the following diseases:
Disease Name |
---|
Breast Invasive Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|